The Federal Government says Nigeria could declare its Ebola outbreak over as early as December 7, 2026, if no further confirmed or probable cases are detected and the country meets the World Health Organization’s (WHO) requirements for ending transmission.
The Coordinating Minister of Health and Social Welfare, Professor Muhammad Ali Pate, disclosed the provisional timeline in a post on his X handle on Monday. He said the Nigeria Centre for Disease Control and Prevention (NCDC) and the WHO must validate the required 42-day countdown, adding that any new case would restart the process.

Nigeria confirmed its Ebola case in the Federal Capital Territory on October 20. According to the WHO, the patient had recently travelled from Uganda, developed symptoms on October 7 and sought medical attention on October 11 before her infection was confirmed. The NCDC said on Sunday that 53 primary contacts linked to the case were being monitored.
Pate said the government’s immediate priority was to monitor identified contacts and strengthen preparedness across health facilities to prevent further transmission. He also reported that the patient was clinically much improved, stable, conscious and communicating, with her laboratory test results approaching baseline levels.
The patient and her husband, identified as a close contact, were medically evacuated to Switzerland on Monday. The Swiss Federal Office of Public Health said the patient was receiving treatment at Geneva University Hospital, while her husband was in isolation at Zurich University Hospital. Swiss authorities said the situation posed no public health risk to the country and that both hospitals had specialised facilities and trained personnel to manage infectious diseases.
Under WHO criteria, an Ebola outbreak can be declared over after 42 consecutive days without a new confirmed case, provided the necessary conditions for ending transmission are met. The December 7 target therefore remains provisional and will depend on surveillance findings and official validation by the NCDC and WHO.




